PHARMACEUTICAL COMPOSITION FOR COMBINATION THERAPY CONTAINING ANTI-C-MET ANTIBODY AND FGFR INHIBITOR

摘要

Provided is a pharmaceutical composition containing anti-c-Met antibody and FGFR inhibitor as active ingredients for a combination therapy for preventing and/or treating cancer diseases. The pharmaceutical composition for a combination therapy has an excellent synergistic effect and can reduce the effective dose of the anti-c-Met antibody, thereby can more effectively treat the cancer.